Refractory epilepsy in adults and the new antiepileptic drugs: the role of gabapentin La epilepsia refractaria del adulto y los antiepilépticos noveles: el rol de la gabapentina.
Author
dc.contributor.author
Galdames,
Author
dc.contributor.author
Aguilera,
Author
dc.contributor.author
Fauré,
Admission date
dc.date.accessioned
2019-01-29T14:55:26Z
Available date
dc.date.available
2019-01-29T14:55:26Z
Publication date
dc.date.issued
1995
Cita de ítem
dc.identifier.citation
Revista médica de Chile, Volumen 123, Issue 4, 2018, Pages 500-508
Identifier
dc.identifier.issn
00349887
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/161368
Abstract
dc.description.abstract
The features of refractory epilepsies and the role of functional surgery and new antiepileptic drugs is reviewed. Among the latter, gabapentin, a drug with peculiar pharmacokinetic properties, is highlighted as a therapeutic alternative in refractory epilepsies and eventually for epileptic patients without previous treatment. A new type of relationship between the pharmaceutical industry and physicians, that privileges clinical research, is discussed.
Refractory epilepsy in adults and the new antiepileptic drugs: the role of gabapentin La epilepsia refractaria del adulto y los antiepilépticos noveles: el rol de la gabapentina.